Advisors Preferred’s Merck MRK Stock Holding History

Advisors Preferred’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Buy	+3,092	New	+$362K	0.06%	146
2024 Q2	–	Sell	-2,901	Closed	-$380K	–	206
2024 Q1	$380K	Sell	2,901 -1,344	-32%	-$166K	0.06%	106
2023 Q4	$481K	Sell	4,245 -1,412	-25%	-$147K	0.08%	95
2023 Q3	$580K	Buy	+5,657	New	+$610K	0.19%	91
2023 Q2	–	Sell	-4,538	Closed	-$494K	–	227
2023 Q1	$494K	Sell	4,538 -922	-17%	-$99.5K	0.17%	61
2022 Q4	$6.07M	Sell	5,460 -979	-15%	-$100K	2.59%	7
2022 Q3	$564K	Sell	6,439 -753	-10%	-$67.2K	0.29%	35
2022 Q2	$656K	Buy	+7,192	New	+$638K	0.17%	71
2022 Q1	–	Sell	-5,571	Closed	-$428K	–	192
2021 Q4	$428K	Sell	5,571 -7	-0.1%	-$558	0.04%	103
2021 Q3	$454K	Buy	5,578 +47	+0.8%	+$3.58K	0.06%	74
2021 Q2	$431K	Sell	5,531 -370	-6%	-$27.5K	0.04%	99
2021 Q1	$434K	Buy	5,901 +2,235	+61%	+$165K	0.06%	108
2020 Q4	$283K	Sell	3,666 -1,030	-22%	-$78.8K	0.05%	133
2020 Q3	$372K	Buy	4,696 +1,468	+45%	+$115K	0.07%	78
2020 Q2	$241K	Buy	+3,228	New	+$243K	0.07%	72
2019 Q1	–	Sell	-907	Closed	-$66K	–	228
2018 Q4	$66K	Buy	+907	New	+$64K	0.08%	78

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Advisors Preferred's MRK Position: Q2 2026 in Review

Advisors Preferred opened a new position in Merck (MRK) in Q2 2026: 3,092 shares worth $401K. The stake represents 0.06% of the portfolio and ranks #146 among its holdings. This is a return to the name: Advisors Preferred previously reported a position in MRK as recently as Q1 2024.

Advisors Preferred first reported a position in MRK in Q4 2018 and has held it in 16 quarters since. The position peaked at $6.07M in Q4 2022. 3,842 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Advisors Preferred held 3,092 shares of Merck worth $401K as of Q2 2026.
Merck was a new Advisors Preferred position in Q2 2026.
Merck made up 0.06% of Advisors Preferred's portfolio in Q2 2026, its #146 holding.
Advisors Preferred first reported a position in Merck in Q4 2018 and has held it in 16 quarters since.
Advisors Preferred's Merck position peaked at $6.07M in Q4 2022.
3,842 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.